Nintedanib and intensive immunosuppressive therapy to treat rapidly progressive interstitial lung disease presenting anti-ARS antibodies

We describe a case of fulminant onset, rapidly progressive-interstitial lung disease (RP-ILD) with anti-ARS antibodies (anti-PL-7). The patient was successfully treated with nintedanib in addition to intensive immunosuppressive therapies, including intravenous cyclophosphamide. Nintedanib has just b...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Respir Med Case Rep
Main Authors: Yanagihara, Toyoshi, Suzuki, Kunihiro, Egashira, Ayaka, Ogo, Naruhiko, Asoh, Tatsuma, Nara, Tsukasa, Takatsuki, Kensaku, Yoshizawa, Seiji, Chong, Sy Giin, Hamada, Naoki, Maeyama, Takashige
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2020
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606860/
https://ncbi.nlm.nih.gov/pubmed/33163354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101272
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares